GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cannabix Technologies Inc (OTCPK:BLOZF) » Definitions » Debt-to-Equity

Cannabix Technologies (Cannabix Technologies) Debt-to-Equity : 0.01 (As of Jan. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cannabix Technologies Debt-to-Equity?

Cannabix Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.03 Mil. Cannabix Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.00 Mil. Cannabix Technologies's Total Stockholders Equity for the quarter that ended in Jan. 2024 was $3.94 Mil. Cannabix Technologies's debt to equity for the quarter that ended in Jan. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cannabix Technologies's Debt-to-Equity or its related term are showing as below:

BLOZF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.02   Max: 0.02
Current: 0.01

During the past 12 years, the highest Debt-to-Equity Ratio of Cannabix Technologies was 0.02. The lowest was 0.01. And the median was 0.02.

BLOZF's Debt-to-Equity is ranked better than
99.86% of 703 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs BLOZF: 0.01

Cannabix Technologies Debt-to-Equity Historical Data

The historical data trend for Cannabix Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabix Technologies Debt-to-Equity Chart

Cannabix Technologies Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.02

Cannabix Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.02 0.02 0.01 0.01

Competitive Comparison of Cannabix Technologies's Debt-to-Equity

For the Medical Devices subindustry, Cannabix Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabix Technologies's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cannabix Technologies's Debt-to-Equity falls into.



Cannabix Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cannabix Technologies's Debt to Equity Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Cannabix Technologies's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabix Technologies  (OTCPK:BLOZF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Cannabix Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cannabix Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabix Technologies (Cannabix Technologies) Business Description

Traded in Other Exchanges
Address
501-3292 Production Way, Burnaby, BC, CAN, V5A 4R4
Cannabix Technologies Inc is in the development of marijuana breathalyzer. It is developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. It is also developing its technology to help employers, law enforcement, government and the public, when marijuana is becoming legal for recreational and medicinal use in many jurisdictions globally. The FAIMS device is designed to operate both independently or coupled in tandem directly to a mass spectrometer, used in forensic labs. The THC Breath Analyzer is a point of care breath testing tool for the rapid detection of recent cannabis use.

Cannabix Technologies (Cannabix Technologies) Headlines